Galectin Therapeutics
Norcross, US
Biotech
Founders & leadership
KD
Kevin D FreemanDirector
JW
Jack W CallicuttExecutive Officer, Director
JC
James C CzirrExecutive Officer, Director
GS
Gilbert S OmennDirector
AR
Arthur R GreenbergDirector
PG
Peter G TraberExecutive Officer, Director
MG
Marc G. RubinDirector
JG
John G. MauldinDirector
GF
Gilbert F AmelioDirector
SG
Steven G. PrelackDirector
Reported raises · per SEC filings
Form D private placements$3MraisedJan 2017 · 5 investors · Pharmaceuticals
Rule 506(b)$1.5MraisedSep 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Undisclosed amountofferedDec 2015 · 6 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.